Amir Reichman

Amir Reichman

Chief Executive Officer at BIONDVAX PHARMACEUTICALS LTD

Net worth: 76 320 $ as of 30/05/2026

51 year
Health Technology
Consumer Services

Profile

Amir Reichman was the founder of NeuroDerm Ltd. since 2003, holding the title of Chief Engineer & Senior Scientist from 2003 to 2009.
Mr. Reichman is currently the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd. since 2021.
Former positions include Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2017 to 2021 and Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina) from 2011 to 2015.
Education includes an undergraduate degree from Ben-Gurion University of the Negev and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/06/2026 67,540,000 ( 0.34% ) 76 320 $ 30/05/2026

Amir Reichman active positions

CompaniesPositionStart
BIONDVAX PHARMACEUTICALS LTD Chief Executive Officer 01/03/2021

Former positions of Amir Reichman

CompaniesPositionEnd
Corporate Officer/Principal 28/02/2021
Novartis Vaccines & Diagnostics, Inc. (North Carolina)
Corporate Officer/Principal 31/12/2014
NEURODERM LTD Founder 31/12/2008
See the detail of Amir Reichman's experience

Training of Amir Reichman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Novartis Vaccines & Diagnostics, Inc. (North Carolina)